2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Michael J. Hennessy Associates, Inc., a full-service health care communications company offering education, research and medical media, introduces The Institute for Value-Based Medicine, a comprehensive online source of timely data, information and perspectives related to value-based medicine.
PLAINSBORO, N.J. (January 27, 2016) — Michael J. Hennessy Associates, Inc., a full-service health care communications company offering education, research and medical media, introduces The Institute for Value-Based Medicine®, a comprehensive online source of timely data, information and perspectives related to value-based medicine.
With a focus on helping translate evidence-based research into value-based decisions, The Institute for Value-Based Medicine provides a platform to evaluate value-based medicine from therapeutic and health economics perspectives in order to help organizations build sustainable and profitable community practices. Directed by a board of highly respected thought leaders and authorities from clinical medicine, the manufacturing sector and payers, the Institute will explore patient care from a clinical position and interpret the impact of value-based programs, alternative payment models and clinical pathways.
In addition to extensive content from OncLive.com (featuring information from Oncology Business Management, Oncology Live®, Oncology Nursing News and Contemporary Oncology), The American Journal of Managed Care®, The American Journal of Accountable Care and MD Magazine®, The Institute for Value-Based Medicine will host a number of live events throughout the year, including the highly anticipated 2016 VB Onc Conference in Miami from March 10-11. This conference will explore critical topics across a variety of therapeutic areas and incorporate engaging panel discussions to arrive at a conclusion on the true worth of value-based medicine.
“The transition toward value-based medicine is in full swing, necessitating a well-informed tool kit that provides stakeholders with not only facts and information, but also insightful opinion and a seat at the discussion table, where all points of view can be aired,” said Michael J. Hennessy Sr., CEO of Michael J. Hennessy Associates. “Health care stakeholders, in an effort to improve outcomes and reduce costs, are shifting the paradigm of medical management from high-volume services to high-quality services focusing on optimal patient outcomes. The Institute’s mission is to provide a platform for timely and relevant discussions that sift through facts and data to ultimately enhance the outcomes of value-based medicine. These in-depth discussions will help shape the future of exceptional patient care.”
About Michael J. Hennessy Associates
A full-service health care communications company offering education, research and medical media, Michael J. Hennessy Associates, Inc. is dedicated to providing health care professionals with the information and resources they need to optimize patient outcomes. The company combines the reach and influence of its powerful portfolio of print and digital product lines, live events, educational programs and custom market research with the customer service focus and customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies.
# # #
Media Contact:
Michael J. LaCosta
Executive Director of Public Relations
Michael J. Hennessy Associates, Inc.
551-655-3718
Related Content: